Literature DB >> 22238220

Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007).

Mickaël Hiligsmann1, Olivier Bruyère, Dominique Roberfroid, Cécile Dubois, Yves Parmentier, Joëlle Carton, Johann Detilleux, Pierre Gillet, Jean-Yves Reginster.   

Abstract

OBJECTIVE: To examine the secular trend of hip fracture incidence in Belgium between 2000 and 2007 and the concomitant change in the prescriptions of antiosteoporosis medications.
METHODS: The incidence of hip fractures and the number of prescriptions were determined using national databases. A logistic regression including years and 5-year age range was performed to assess the secular trend of hip fracture incidence, and Pearson's correlation coefficient was calculated to examine the relationship between hip fracture incidence and the prescriptions of antiosteoporosis medications.
RESULTS: The annual number of hip fractures increased in Belgium from 13,512 in 2000 to 14,744 in 2007, with a more marked increased in men (20.4%) than in women (5.7%). The age-adjusted incidence of hip fractures was significantly decreased by 1.12% per year in women, but declined nonsignificantly by 0.34% per year in men. An increase in the prescriptions of antiosteoporosis medications in women was observed during the same time period.
CONCLUSION: Despite an increase in the number of hip fractures in Belgium between 2000 and 2007, there was a significant decrease in age-adjusted incidence in women but not in men. Although our results suggest that the decrease may be related to the extent of antiosteoporosis medications, a causal relationship cannot be ascertained and many other factors may have contributed to the decrease in age-adjusted incidence.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238220     DOI: 10.1002/acr.21607

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  11 in total

Review 1.  Geographic and ethnic disparities in osteoporotic fractures.

Authors:  Jane A Cauley; Didier Chalhoub; Ahmed M Kassem; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2014-04-22       Impact factor: 43.330

2.  Estrogens, the be-all and end-all of male hypogonadal bone loss?

Authors:  M R Laurent; E Gielen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2014-11-07       Impact factor: 4.507

3.  Hip fracture incidence 2003-2013 and projected cases until 2050 in Austria: a population-based study.

Authors:  Hans Concin; Wolfgang Brozek; Karl-Peter Benedetto; Hartmut Häfele; Joachim Kopf; Thomas Bärenzung; Richard Schnetzer; Christian Schenk; Elmar Stimpfl; Ursula Waheed-Hutter; Hanno Ulmer; Kilian Rapp; Elisabeth Zwettler; Gabriele Nagel
Journal:  Int J Public Health       Date:  2016-08-22       Impact factor: 3.380

Review 4.  The clinical epidemiology of male osteoporosis: a review of the recent literature.

Authors:  Tina Willson; Scott D Nelson; Jonathan Newbold; Richard E Nelson; Joanne LaFleur
Journal:  Clin Epidemiol       Date:  2015-01-09       Impact factor: 4.790

5.  Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.

Authors:  O Ethgen; M Hiligsmann; N Burlet; J-Y Reginster
Journal:  Osteoporos Int       Date:  2015-09-22       Impact factor: 4.507

6.  Thirty years of hip fracture incidence in Austria: is the worst over?

Authors:  Hans Peter Dimai; Berthold Reichardt; Emanuel Zitt; Hans Concin; Oliver Malle; Astrid Fahrleitner-Pammer; Axel Svedbom; Wolfgang Brozek
Journal:  Osteoporos Int       Date:  2021-08-15       Impact factor: 4.507

7.  Changing trends in the epidemiology of hip fracture in Spain.

Authors:  R Azagra; F López-Expósito; J C Martin-Sánchez; A Aguyé; N Moreno; C Cooper; A Díez-Pérez; E M Dennison
Journal:  Osteoporos Int       Date:  2013-12-10       Impact factor: 4.507

Review 8.  Health technology assessment in osteoporosis.

Authors:  Mickael Hiligsmann; John A Kanis; Juliet Compston; Cyrus Cooper; Bruno Flamion; Pierre Bergmann; Jean-Jacques Body; Steven Boonen; Olivier Bruyere; Jean-Pierre Devogelaer; Stefan Goemaere; Jean-Marc Kaufman; Serge Rozenberg; Jean-Yves Reginster
Journal:  Calcif Tissue Int       Date:  2013-03-21       Impact factor: 4.333

9.  Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

Authors:  M Hiligsmann; W Ben Sedrine; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2013-02-01       Impact factor: 4.507

Review 10.  Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures.

Authors:  Olivier Ethgen; Mickaël Hiligsmann; Nansa Burlet; Jean-Yves Reginster
Journal:  Arch Public Health       Date:  2015-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.